BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18835953)

  • 1. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.
    Pradhan AD; Cook NR; Manson JE; Ridker PM; Buring JE
    Diabetes Care; 2009 Jan; 32(1):3-8. PubMed ID: 18835953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial.
    Liu S; Lee IM; Song Y; Van Denburgh M; Cook NR; Manson JE; Buring JE
    Diabetes; 2006 Oct; 55(10):2856-62. PubMed ID: 17003353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
    Lee IM; Cook NR; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):56-65. PubMed ID: 15998891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics of participants in the Women's Health Study.
    Rexrode KM; Lee IM; Cook NR; Hennekens CH; Buring JE
    J Womens Health Gend Based Med; 2000; 9(1):19-27. PubMed ID: 10718501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Matsumoto C; Soejima H; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y;
    Diabetes Care; 2018 Aug; 41(8):1757-1764. PubMed ID: 29909377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
    Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
    Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
    Sacco M; Pellegrini F; Roncaglioni MC; Avanzini F; Tognoni G; Nicolucci A;
    Diabetes Care; 2003 Dec; 26(12):3264-72. PubMed ID: 14633812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer.
    Buring JE
    Cleve Clin J Med; 2006 Sep; 73(9):863-70. PubMed ID: 16970138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS; McCloskey C; Prasad R; Bezlyak V
    Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women.
    Song Y; Manson JE; Buring JE; Liu S
    Diabetes Care; 2004 Jan; 27(1):59-65. PubMed ID: 14693967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals.
    Erkan D; Harrison MJ; Levy R; Peterson M; Petri M; Sammaritano L; Unalp-Arida A; Vilela V; Yazici Y; Lockshin MD
    Arthritis Rheum; 2007 Jul; 56(7):2382-91. PubMed ID: 17599766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
    Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
    Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.
    Hira RS; Kennedy K; Nambi V; Jneid H; Alam M; Basra SS; Ho PM; Deswal A; Ballantyne CM; Petersen LA; Virani SS
    J Am Coll Cardiol; 2015 Jan; 65(2):111-21. PubMed ID: 25593051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.
    Sesso HD; Buring JE; Christen WG; Kurth T; Belanger C; MacFadyen J; Bubes V; Manson JE; Glynn RJ; Gaziano JM
    JAMA; 2008 Nov; 300(18):2123-33. PubMed ID: 18997197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.
    de Gaetano G;
    Lancet; 2001 Jan; 357(9250):89-95. PubMed ID: 11197445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
    Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
    Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.